title: The contribution of the vaccine adverse event text mining system to the classification of possible Guillain-Barré syndrome reports.
abstract: BACKGROUND
  We previously demonstrated that a general purpose text mining system, the Vaccine adverse event Text Mining (VaeTM) system, could be used to automatically classify reports of an-aphylaxis for post-marketing safety surveillance of vaccines.
  
  
  OBJECTIVE
  To evaluate the ability of VaeTM to classify reports to the Vaccine Adverse Event Reporting System (VAERS) of possible Guillain-Barré Syndrome (GBS).
  
  
  METHODS
  We used VaeTM to extract the key diagnostic features from the text of reports in VAERS. Then, we applied the Brighton Collaboration (BC) case definition for GBS, and an information retrieval strategy (i.e. the vector space model) to quantify the specific information that is included in the key features extracted by VaeTM and compared it with the encoded information that is already stored in VAERS as Medical Dictionary for Regulatory Activities (MedDRA) Preferred Terms (PTs). We also evaluated the contribution of the primary (diagnosis and cause of death) and secondary (second level diagnosis and symptoms) diagnostic VaeTM-based features to the total VaeTM-based information.
  
  
  RESULTS
  MedDRA captured more information and better supported the classification of reports for GBS than VaeTM (AUC: 0.904 vs. 0.777); the lower performance of VaeTM is likely due to the lack of extraction by VaeTM of specific laboratory results that are included in the BC criteria for GBS. On the other hand, the VaeTM-based classification exhibited greater specificity than the MedDRA-based approach (94.96% vs. 87.65%). Most of the VaeTM-based information was contained in the secondary diagnostic features.
  
  
  CONCLUSIONS
  For GBS, clinical signs and symptoms alone are not sufficient to match MedDRA coding for purposes of case classification, but are preferred if specificity is the priority.
authors: T
authors: T
authors: Botsis
authors: E J
authors: EJ
authors: Woo
authors: R
authors: R
authors: Ball
mesh_terms: D057225:Data Mining / Q000379:methods*; D020275:Guillain-Barre Syndrome / Q000209:etiology*; D006801:Humans; D058028:Research Report; D014612:Vaccines / Q000009:adverse effects*
chemical_list: D014612:Vaccines
keywords: Biosurveillance and case reporting; and analysis; data access; data mining; data repositories; integration; natural language processing
references: Int J Med Inform. 2009 Dec;78(12):e97-e103
references: 19230751
references: Vaccine. 2011 Jan 10;29(3):599-612
references: 20600491
references: Drug Saf. 2013 Jul;36(7):573-82
references: 23703591
references: Vaccine. 2002 Dec 13;21(3-4):298-302
references: 12450705
references: AMIA Annu Symp Proc. 2010 Nov 13;2010:281-5
references: 21346985
references: J Am Med Inform Assoc. 2012 Nov-Dec;19(6):1011-8
references: 22922172
references: Pediatr Infect Dis J. 2004 Apr;23(4):287-94
references: 15071280
references: Stud Health Technol Inform. 2011;166:25-30
references: 21685607
references: J Asthma Allergy. 2012;5:1-9
references: 22690127
references: Int J Med Inform. 2005 Aug;74(7-8):563-71
references: 15955732
references: J Am Med Inform Assoc. 2011 Sep-Oct;18(5):631-8
references: 21709163
references: AMIA Annu Symp Proc. 2006;:1122
references: 17238741
references: BMC Med Inform Decis Mak. 2007 Feb 12;7:3
references: 17295907
references: Clin Pharmacol Ther. 2012 Jun;91(6):1010-21
references: 22549283
references: Drug Saf. 2004;27(8):591-602
references: 15154830
references: Drug Saf. 1999 Feb;20(2):109-17
references: 10082069
references: Biol Pharm Bull. 2012;35(6):967-70
references: 22687540